Short-and mid-term intravascular ultrasound analysis of the new zotarolimus-eluting stent with durable polymer: Results from the RESOLUTE trial

Katsuhisa Waseda, Junya Ako, Masao Yamasaki, Tomomi Koizumi, John Ormiston, Stephen Worthley, Robert Whitbourn, Darren Walters, Yasuhiro Honda, Ian Meredith, Peter Fitzgerald

Research output: Contribution to journalArticleResearchpeer-review

17 Citations (Scopus)


The Resolute stent is a newly developed system with a bio-histocompatible polymer that allows programmed drug delivery up to 180 days. The aim of this intravascular ultrasound (IVUS) analysis was to evaluate the short- (4 months) and mid-term (9 months) efficacy using the Resolute stent.
Original languageEnglish
Pages (from-to)2097 - 2102
Number of pages6
JournalCirculation Journal
Issue number10
Publication statusPublished - 2010

Cite this